July 27, 2025. We are excited to announce that our company is attending the Alzheimer’s Association International Conference 2025 (AAIC25) in Toronto, Canada, from July 27 to July 31, 2025.
The AAIC is the world’s largest and most influential meeting dedicated to advancing dementia science. Organized by the Alzheimer’s Association, this global forum brings together researchers, clinicians, and industry leaders to share the latest findings, innovations, and breakthroughs in Alzheimer’s and dementia research.
Our team is looking forward to connecting with fellow scientists, healthcare professionals, and partners to discuss the MAP-AD® Test and strengthen our commitment to improving the lives of those affected by Alzheimer’s disease providing a prognostic tool that identifies Alzheimer’s dementia progression in Mild Cognitive Impairment patients, independently of their b-amyloid status.
If you’re attending #AAIC25, we’d love to meet you! Reach out to connect with us during the conference at booth #1614 and poster #98536.
